• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对实验猴进行针对人类疟原虫恶性疟原虫的有效免疫接种。

An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum.

作者信息

Siddiqui W A

出版信息

Science. 1977 Jul 22;197(4301):388-9. doi: 10.1126/science.406671.

DOI:10.1126/science.406671
PMID:406671
Abstract

This is the first report of successful immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum. Of the five owl monkeys (Aotus trivirgatus) used in this pilot study, two served as controls and the other three were immunized with P. falciparum antigen consisting primarily of mature segmenters containing fully developed merozoites. Two injections of antigen emulsified with Freund's complete adjuvant were administered intramuscularly 3 weeks apart. Three weeks after the second vaccination, all monkeys were challenged with the homologous strain of P. falciparum. The control monkeys died with high levels of parasitemia within 2 weeks of challenge. The three immunized monkeys survived and showed strong protection against P. falciparum. These results are encouraging for the possible future development of an effective vaccine against human malaria.

摘要

这是关于实验猴成功免疫人类疟原虫——恶性疟原虫的首份报告。在这项初步研究中使用的五只夜猴(Aotus trivirgatus)里,两只作为对照,另外三只用主要由含有完全发育裂殖子的成熟裂殖体组成的恶性疟原虫抗原进行免疫。每隔3周肌肉注射两次与弗氏完全佐剂乳化的抗原。第二次接种疫苗3周后,所有猴子都用恶性疟原虫的同源菌株进行攻击。对照猴在攻击后2周内死于高血寄生虫血症。三只免疫的猴子存活下来,并对恶性疟原虫表现出强大的抵抗力。这些结果对于未来开发有效的人类疟疾疫苗具有鼓舞作用。

相似文献

1
An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum.对实验猴进行针对人类疟原虫恶性疟原虫的有效免疫接种。
Science. 1977 Jul 22;197(4301):388-9. doi: 10.1126/science.406671.
2
Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant.针对恶性疟原虫对实验猴进行疫苗接种:一种可能的安全佐剂。
Science. 1978 Sep 29;201(4362):1237-9. doi: 10.1126/science.99814.
3
Immunization of experimental monkeys against Plasmodium falciparum: use of synthetic adjuvants.用合成佐剂对实验猴进行恶性疟原虫免疫接种
Bull World Health Organ. 1979;57 Suppl 1(Suppl):199-203.
4
Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant.恶性疟原虫重组SERA蛋白在夜猴中诱导的保护性免疫:使用SERA 1和MF75.2佐剂的进一步研究
Infect Immun. 1993 May;61(5):2048-52. doi: 10.1128/iai.61.5.2048-2052.1993.
5
Merozoite vaccination of douroucouli monkeys against falciparum malaria.夜猴的裂殖子疫苗接种预防恶性疟原虫疟疾
Lancet. 1977 Jun 25;1(8026):1335-8. doi: 10.1016/s0140-6736(77)92551-x.
6
Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans).用恶性疟原虫环状感染红细胞表面抗原对夜猴(Aotus vociferans)进行免疫试验。
Am J Trop Med Hyg. 1988 Mar;38(2):268-82. doi: 10.4269/ajtmh.1988.38.268.
7
Partial protection of Plasmodium falciparum-vaccinated Aotus trivirgatus against a challenge of a heterologous strain.恶性疟原虫疫苗接种的三带犰狳对异源菌株攻击的部分保护作用。
Am J Trop Med Hyg. 1978 Nov;27(6):1277-8. doi: 10.4269/ajtmh.1978.27.1277.
8
A study of cellular and humoral immune responses in owl monkeys (Aotus trivirgatus) following vaccination against Plasmodium falciparum.对猫头鹰猴(Aotus trivirgatus)接种恶性疟原虫疫苗后的细胞免疫和体液免疫反应的研究。
Bull World Health Organ. 1979;57 Suppl 1(Suppl):247-53.
9
Immunization of Aotus trivirgatus against Plasmodium falciparum with irradiated blood forms.用经辐照的血液形态对三带夜猴进行恶性疟原虫免疫接种。
Bull World Health Organ. 1979;57 Suppl 1(Suppl):153-7.
10
Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.用恶性疟原虫环感染红细胞表面抗原对夜猴进行免疫接种。
Am J Trop Med Hyg. 1991 Jan;44(1):34-41. doi: 10.4269/ajtmh.1991.44.34.

引用本文的文献

1
Erythrocyte invasion in malaria: from molecular mechanisms to rational vaccines.疟疾中的红细胞入侵:从分子机制到合理疫苗
Nat Rev Microbiol. 2025 Sep 15. doi: 10.1038/s41579-025-01235-1.
2
Malaria vaccines: a new era of prevention and control.疟疾疫苗:预防和控制的新时代。
Nat Rev Microbiol. 2024 Dec;22(12):756-772. doi: 10.1038/s41579-024-01065-7. Epub 2024 Jul 18.
3
The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for .新型无性血期疟疾疫苗候选物的需求。
Biomolecules. 2024 Jan 12;14(1):100. doi: 10.3390/biom14010100.
4
Sterile protection against malaria by repeated blood stage infection in the monkey model.经重复血期感染对猴子模型中的疟疾进行无菌保护。
Life Sci Alliance. 2023 Dec 29;7(3). doi: 10.26508/lsa.202302524. Print 2024 Mar.
5
Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects.疟疾疫苗:60年的希望之旅与最终成功——经验教训与未来展望
Trop Med Health. 2023 May 17;51(1):29. doi: 10.1186/s41182-023-00516-w.
6
Current approaches to malaria vaccines.疟疾疫苗的当前方法。
Curr Opin Microbiol. 2022 Dec;70:102227. doi: 10.1016/j.mib.2022.102227. Epub 2022 Nov 4.
7
Malaria vaccines since 2000: progress, priorities, products.2000年以来的疟疾疫苗:进展、优先事项与产品
NPJ Vaccines. 2020 Jun 9;5(1):48. doi: 10.1038/s41541-020-0196-3. eCollection 2020.
8
Structure Solves the Problem with Malaria Merozoite Vaccines.结构解决了疟疾裂殖子疫苗的问题。
Trends Parasitol. 2019 Nov;35(11):855-857. doi: 10.1016/j.pt.2019.09.004. Epub 2019 Oct 14.
9
Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective.保守结合区域为基于肽的疫苗开发提供线索:化学视角。
Molecules. 2017 Dec 12;22(12):2199. doi: 10.3390/molecules22122199.
10
Acquired immunity to malaria.获得性疟疾免疫力。
Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents. doi: 10.1128/CMR.00025-08.